PPARγ activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction.
- DOI
- 10.1016/j.phrs.2026.108193
- Published
- 2026 May
- Container
- Pharmacological research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.phrs.2026.108193,
title = {PPARγ activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction.},
author = {Cavestro C and Cascone F and Legati A and Izzo R and Catania M and Vergara C and Rodríguez-Pascau L and Pizcueta P and Tiranti V and Di Meo I},
year = {2026},
journal = {Pharmacological research},
doi = {10.1016/j.phrs.2026.108193},
url = {https://doi.org/10.1016/j.phrs.2026.108193}
}RIS
TY - JOUR TI - PPARγ activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction. AU - Cavestro C AU - Cascone F AU - Legati A AU - Izzo R AU - Catania M AU - Vergara C AU - Rodríguez-Pascau L AU - Pizcueta P AU - Tiranti V AU - Di Meo I PY - 2026 JO - Pharmacological research DO - 10.1016/j.phrs.2026.108193 UR - https://doi.org/10.1016/j.phrs.2026.108193 ER -
APA
C, C., F, C., A, L., R, I., M, C., C, V., L, R., P, P., V, T., & I, D. M. (2026). PPARγ activation by leriglitazone counteracts neurodegeneration and neuroinflammation in a disease-relevant mouse model of COASY dysfunction.. Pharmacological research. https://doi.org/10.1016/j.phrs.2026.108193
Source records
- pubmed · retrieved 2026-09-25T21:41:10.434Z